Showing results (411-420 of 2,504) with videos related to
Sort By:
Pageof 251
Endocrine-Related Cancer|January 19, 2013
Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patientsYing-Cheng Chiang, Ming-Cheng Chang, Pao-Jen Chen, et al.Endocrine-Related Cancer|February 14, 2013
MEK inhibition leads to lysosome-mediated Na+/I- symporter protein degradation in human breast cancer cellsZhaoxia Zhang, Sasha Beyer, Sissy M JhiangEndocrine-Related Cancer|February 14, 2013
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association ConsortiumCatherine M Olsen, Christina M Nagle, David C Whiteman, et al.Endocrine-Related Cancer|September 10, 2013
Concurrent overexpression of RET/PTC1 and TTF1 confers tumorigenicity to thyrocytesToyoshi Endo, Tetsuro KobayashiEndocrine-Related Cancer|December 3, 2013
The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumorsJessica Svedlund, Elham Barazeghi, Peter Stålberg, et al.Endocrine-Related Cancer|December 5, 2013
NRF2 immunolocalization in human breast cancer patients as a prognostic factorYoshiaki Onodera, Hozumi Motohashi, Kiyoshi Takagi, et al.Endocrine-Related Cancer|December 5, 2013
Sorafenib in the treatment of radioiodine-refractory differentiated thyroid cancer: a meta-analysisChen-Tian Shen, Zhong-Ling Qiu, Quan-Yong LuoEndocrine-Related Cancer|December 5, 2013
The role of the inflammatory microenvironment in thyroid carcinogenesisLucas Leite Cunha, Marjory Alana Marcello, Laura Sterian WardEndocrine-Related Cancer|January 16, 2013
IGF2 increases de novo steroidogenesis in prostate cancer cellsAmy A Lubik, Jennifer H Gunter, Brett G Hollier, et al.Endocrine-Related Cancer|January 16, 2013
Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancerCarlien Leyssens, Lieve Verlinden, Annemieke VerstuyfPageof 251